DOJ probes trading in herbal medicine firm that surged 46,000%

Businesstimes
2025.11.02 01:00
portai
I'm PortAI, I can summarize articles.

The US Department of Justice is investigating Regencell Bioscience, a Hong-Kong based traditional Chinese medicine company, after its stock surged 46,000%. The DOJ has issued a subpoena for documents related to trading and corporate matters. Regencell, which has not generated revenue since its Nasdaq debut in 2021, attributes the volatility to potential short squeezes or unusual trading activity. The company is cooperating with the investigation but cannot predict its outcome.

Source: Businesstimes The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.